You are here » Home » Companies » Company Overview » Hester Biosciences Ltd

Hester Biosciences Ltd.

BSE: 524669 Sector: Health care
NSE: HESTERBIO ISIN Code: INE782E01017
BSE 00:00 | 25 May 1402.65 -5.60
(-0.40%)
OPEN

1412.00

HIGH

1443.10

LOW

1400.00

NSE 00:00 | 25 May 1404.75 -9.35
(-0.66%)
OPEN

1416.15

HIGH

1435.00

LOW

1390.00

OPEN 1412.00
PREVIOUS CLOSE 1408.25
VOLUME 79
52-Week high 1949.80
52-Week low 816.00
P/E 39.05
Mkt Cap.(Rs cr) 1,194
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00
OPEN 1412.00
CLOSE 1408.25
VOLUME 79
52-Week high 1949.80
52-Week low 816.00
P/E 39.05
Mkt Cap.(Rs cr) 1,194
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00

Hester Biosciences Ltd. (HESTERBIO) - Company History

Incorporated as a private limited company in Apr.'87, Hester Pharmaceutical (HPL) was converted into a public limited company in Nov.'93. HPL markets and distributes veterinary and pharmaceutical products like animal health products, poultry vaccines, poultry diagnostic, laboratory kits and reagents. It markets the veterinary products of many international companies including Ghen Corporation, Japan; Maine Biological Laboratories, US; Idexx Corporation, US; International Diagnostic Systems Corporation, US; Biogal Galed Laboratories, Israel; and Kemin Europa, Belgium. The company's own production of veterinary vaccines (in Vials) is expected to commence soon. HPL has technical collaborations with Maine Biological Laboratories and Ghen Corporation. During 1996-97, company successfully implemented veterinary vaccine and commercial production has begun. The company has received licenses for producing 10 additional poultry vaccines.It has also signed an manufacturing agreement with Sinsui Inc for producing poultry vaccines.